Two Midwestern Health Systems Standardize TwitchView® Train of Four Monitor
News related to:Blink Anesthesia · 1 min read
SEATTLE, Sept. 23, 2026 /CourierPR/ -- Blink Anesthesia, a Seattle-based medical device company, has announced that two additional academic integrated delivery networks (IDNs) in the Midwest have standardized the TwitchView® Train of Four (TOF) Monitor across their surgical departments. This move marks a significant step in the broader trend of academic health systems adopting quantitative neuromuscular monitoring as the standard of care.
One health system has completed its system-wide deployment, while the second is on track to complete its rollout by the end of the year. By standardizing TwitchView®, both systems aim to establish a consistent, quantitative approach to neuromuscular blockade management, support alignment with the 2023 American Society of Anesthesiologists (ASA) guidelines, and reduce costs associated with preventable postoperative complications and avoidable drug spend.
The deployment of TwitchView® reflects a commitment to improving patient safety and operational efficiency.
The advancements in the TwitchView® platform are designed to support the 2023 ASA guidelines for monitoring and antagonism of neuromuscular blockade, ensuring that anesthetists can eliminate residual paralysis and improve patient outcomes.
Blink Anesthesia continues to expand its footprint across academic, community, and integrated health systems. The company anticipates further system-wide deployments in the coming year, as it seeks to further its mission of improving patient safety in anesthesia practice. The adoption of TwitchView® by these academic health systems underscores the growing recognition of quantitative neuromuscular monitoring as a critical tool in modern anesthesia care.
The TwitchView® Train of Four Monitor is a quantitative neuromuscular monitor that helps anesthetists eliminate residual paralysis and allows hospitals to align with the 2023 ASA guidelines for monitoring and antagonism of neuromuscular blockade. By standardizing this technology, health systems can ensure consistent and reliable monitoring, reducing the risk of postoperative complications and optimizing patient care.